Brind.

Editas Medicine and Bristol Myers Squibb triggered a milestone payment related to their collaboration.

1 report, 1 independent Updated Aug 13

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Editas Medicine Bristol-Myers Squibb

Keep exploring

The entities involved

Editas Medicine
discovery-phase pharmaceutical company

Nothing else this week.
Bristol-Myers Squibb
American pharmaceutical company
- Bristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Mon 13:45
- FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09

Coverage

Newest first; wire copies grouped

Aug 13GlobeNewswireEditas Medicine Announces Second Quarter 2025 Results and Business Updates Company to select lead development candidate in September; on track to file IND by mid-2026 and achieve human proof-of-conce